^
7d
MYCOHYPE: An RCT of Mycophenolate Mofetil (MMF) in Fibrotic Hypersensitivity Pneumonitis (clinicaltrials.gov)
P4, N=144, Active, not recruiting, Post Graduate Institute of Medical Education and Research, Chandigarh | Recruiting --> Active, not recruiting | Trial completion date: Oct 2025 --> Oct 2026 | Trial primary completion date: Sep 2025 --> Sep 2026
Enrollment closed • Trial completion date • Trial primary completion date
|
prednisolone
13d
New P3 trial
|
FOLH1 positive
|
enzalutamide • abiraterone acetate • Nubeqa (darolutamide) • cabazitaxel • apalutamide • Xofigo (radium Ra-223 dichloride) • AiRuiEn (rezvilutamide) • FPI-2265 • prednisolone
16d
Unmasking peripheral T-cell lymphoma in dermatomyositis with anti-PM/Scl-100 and anti-Mi-2 positivity: a case-based review. (PubMed, Rheumatol Int)
She was diagnosed with DM and treated with oral prednisolone...These cases suggest that repeat tissue evaluation, particularly of skin lesions, may be critical in atypical or treatment-refractory cases. Our case highlights that even a DM phenotype with autoantibodies generally considered less strongly associated with malignancy does not exclude occult lymphoma in elderly patients.
Review • Journal
|
IL2 (Interleukin 2)
|
prednisolone
1m
COLTHYR: Colchicine for Autoimmune and Subacute Thyroiditis (clinicaltrials.gov)
P2/3, N=300, Not yet recruiting, Mansoura University
New P2/3 trial
|
prednisolone
2ms
Clinicopathological Features, Treatment Response, and Outcome of Rosai-Dorfman Disease in Two Children. (PubMed, Clin Case Rep)
He responded poorly to cytotoxic drugs, but achieved a durable complete remission with three cycles of oral prednisolone...However, he achieved complete remission with a combination of oral methotrexate and vincristine...There is no universal standard guideline for managing Rosai-Dorfman disease. However, patients with symptomatic disease, those experiencing emergency symptoms, and cases of relapse will require medical or surgical intervention to improve their outcomes.
Journal
|
CD68 (CD68 Molecule)
|
methotrexate • vincristine • prednisolone
2ms
Trial completion
|
prednisolone
2ms
042011: LCH-IV International Collaborative Treatment Protocol for Children and Adolescents with Langerhans Cell Histiocytosis (2024-512676-36-00)
P2/3, N=1124, Active, not recruiting, St. Anna Childrens Cancer Research Institute GmbH | Not yet recruiting --> Active, not recruiting
Enrollment closed
|
cytarabine • methotrexate • cladribine • melphalan • fludarabine IV • mercaptopurine • vinblastine • prednisolone
2ms
GLITZ: Oral Itraconazole Versus Combination of Systemic Glucorticoids and Oral Itraconazole in CPA-ABPA Overlap Syndrome (clinicaltrials.gov)
P=N/A, N=104, Recruiting, Post Graduate Institute of Medical Education and Research, Chandigarh | Trial completion date: Dec 2025 --> Feb 2027 | Trial primary completion date: Dec 2024 --> Jan 2027
Trial completion date • Trial primary completion date
|
prednisone • itraconazole • prednisolone
3ms
Trial completion
|
prednisolone
3ms
CalciTx: CALCIGRAN FORTE AND DOSING OF IMMUNOSUPPRESSIVE DRUGS IN KIDNEY TRANSPLANT RECIPIENTS (2024-515164-30-00)
P4, N=26, Completed, Oslo University Hospital HF | Not yet recruiting --> Completed
Trial completion
|
prednisolone
4ms
SELECT-TAK: A Study to Evaluate the Efficacy and Safety of Upadacitinib in Participants With Takayasu Arteritis (TAK) (clinicaltrials.gov)
P3, N=56, Active, not recruiting, AbbVie | Trial completion date: Aug 2027 --> Aug 2028 | Trial primary completion date: Aug 2027 --> Aug 2028
Trial completion date • Trial primary completion date
|
prednisolone
4ms
New trial
|
prednisolone